Victorian closed-track driving trial delayed to 2027 by Adam Sheldon February 18, 2026February 19, 2026 Victoria’s closed-track medicinal cannabis driving trial will not report to the state government until 2027 and […]
News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026June 8, 2026
New tech platform aims to ‘flip power back’ to local pharmacies by Adam Sheldon February 18, 2026February 18, 2026
‘Game changer’: Tasmania allows pharmacists to fill interstate prescriptions by Adam Sheldon February 17, 2026February 17, 2026
Veterans facing fresh restrictions on subsidised medicinal cannabis by Steve Jones February 16, 2026February 19, 2026
Sector warns of potential ‘high human cost’ of limiting medicinal cannabis access by Steve Jones February 16, 2026June 8, 2026
Industry calls for reform agenda focused on ‘evolution’ that preserves patient access by Steve Jones February 12, 2026June 8, 2026
New cultivator plots a different path to avoid the perils of ‘over expansion’ by Steve Jones February 12, 2026February 12, 2026
News in brief: MedReleaf expands product range; Bioxyne receives first psilocybin order; Greencare names medical lead by Steve Jones February 11, 2026June 8, 2026
